Best Practice & Research Clinical Endocrinology & Metabolism
Volume 21, Issue 2 , Pages 193-208 , June 2007

New insights into thyroid hormone action

  • Paul M. Yen (Associate Professor)

      Affiliations

    • Corresponding Author InformationCorresponding author. Endocrinology Division, Department of Medicine, John Hopkins Bayview Medical Center, 5200 Eastern Avenue, Room 432, Baltimore, MD 21224, USA. Tel.: +1 410 550 1772; Fax: +1 410 550 6864.

References 

  1. Hetzel BS. Iodine and neuropsychological development. The Journal of Nutrition. 2000;130:493S–495S
  2. Yen PM. Physiological and molecular basis of thyroid hormone action. Physiological Reviews. 2001;81:1097–1142
  3. Tata JR, Widnell CC. Ribonucleic acid synthesis during the early action of thyroid hormones. Biochemical Journal. 1966;98:604–629
  4. Oppenheimer JH, Schwartz HL, Surks MI. Tissue differences in the concentration of triiodothyronine nuclear binding sites in the rat: liver, kidney, pituitary, heart, brain, spleen, and testis. Endocrinology. 1974;95:897–903
  5. Samuels HH, Tsai JS. Thyroid hormone action in cell culture: Demonstration of nuclear receptors in intact cells and isolated nuclei. Proceedings of the National Academy of Sciences of the United States of America. 1973;70:3488–3492
  6. Sap J, Munoz A, Damm K. The c-erbA protein is a high affinity receptor for thyroid hormone. Nature. 1986;324:635–640
  7. Weinberger C, Thompson CC, Ong ES, et al. The c-erbA gene encodes a thyroid hormone receptor. Nature. 1986;324:641–646
  8. Kohrle J. The selenoenzyme family of deiodinase isozymes controls local thyroid hormone availability. Reviews in Endocrine and Metabolic Disorders. 2000;1:49–58
  9. Jansen J, Friesema EC, Milici C, et al. Thyroid hormone transporters in health and disease. Thyroid. 2005;15:757–768
  10. McKenna NJ, Lanz RB, O'Malley BW. Nuclear receptor coregulators: cellular and molecular biology. Endocrine Reviews. 1999;20:321–344
  11. Zhang J, Lazar MA. The mechanism of action of thyroid hormones. Annual Review of Physiology. 2000;62:439–466
  12. Wagner RL, Apriletti JW, McGrath ME, et al. A structural role for hormone in the thyroid hormone receptor. Nature. 1995;378:690–697
  13. Perissi V, Staszewski LM, McInerney EM, et al. Molecular determinants of nuclear receptor-corepressor interaction. Genes & Development. 1999;13:3198–3208
  14. Nagy L, Kao HY, Love JD, et al. Mechanism of corepressor binding and release from nuclear hormone receptors. Genes & Development. 1999;13:3209–3216
  15. Feng W, Ribeiro RC, Wagner RL, et al. Hormone-dependent coactivator binding to a hydrophobic cleft on nuclear receptors. Science. 1998;280:1747–1749
  16. Hu X, Lazar MA. The CoRNR motif controls the recruitment of corepressors by nuclear hormone receptors. Nature. 1999;402:93–96
  17. Lazar MA, Hodin RA, Chin WW. Human carboxyl-terminal variant of a-type c-erbA inhibits trans-activation by thyroid hormone receptors without binding thyroid hormone. Proceedings of the National Academy of Sciences of the United States of America. 1989;86:7771–7774
  18. Lazar MA, Hodin RA, Darling DS, et al. A novel member of the thyroid/steroid hormone receptor family is encoded by the opposite strand of the rat c-erbAa transcriptional unit. Molecular and Cellular Biology. 1989;9:1128–1136
  19. Miyajima N, Horiuchi R, Shibuya Y, et al. Two erbA homologs encoding proteins with different T3 binding capacities are transcribed from opposite DNA strands of the same genetic locus. Cell. 1989;57:31–39
  20. Chawla A, Lazar MA. Induction of Rev-ErbA alpha, an orphan receptor encoded on the opposite strand of the alpha-thyroid hormone receptor gene, during adipocyte differentiation. Journal of Biological Chemistry. 1993;268:16265–16269
  21. Hodin RA, Lazar MA, Wintman BI, et al. Identification of a novel thyroid hormone receptor that is pituitary-specific. Science. 1989;244:76–79
  22. Lazar MA. Thyroid hormone receptors: Multiple forms, multiple possibilities. Endocrine Reviews. 1993;14:348–399
  23. Hodin RA, Lazar MA, Chin WW. Differential and tissue-specific regulation of the multiple rat c-erbA mRNA species by thyroid hormone. The Journal of Clinical Investigation. 1990;85:101–105
  24. Yen PM, Sunday ME, Darling DS, et al. Isoform-specific thyroid hormone receptor antibodies detect multiple thyroid hormone receptors in rat and human pituitaries. Endocrinology. 1992;130:1539–1546
  25. Bradley DJ, Towle HC, Young WS. Alpha and beta thyroid hormone receptor (TR) gene expression during auditory neurogenesis: evidence for TR isoform-specific transcriptional regulation in vivo. Proceedings of the National Academy of Sciences of the United States of America. 1994;91:439–443
  26. Cook CB, Kakucska I, Lechan RM, et al. Expression of thyroid hormone receptor b2 in rat hypothalamus. Endocrinology. 1992;130:1077–1079
  27. Sjoberg M, Vennstrom B, Forrrest D. Thyroid hormone receptors in chick retinal development: differential expression of mRNAs for alpha and N-terminal variant beta receptors. Development. 1992;114:39–47
  28. Chassande O, Fraichard A, Gauthier K, et al. Identification of transcripts initiated from an internal promoter in the c-erbA alpha locus that encode inhibitors of retinoic acid receptor-alpha and triiodothyronine receptor activities. Molecular Endocrinology. 1997;11:1278–1290
  29. Williams G. Cloning and characterization of two novel thyroid hormone receptors b isoforms. Molecular and Cellular Biology. 2000;20:8329–8342
  30. Farsetti A, Desvergne B, Hallenbeck P, et al. Characterization of myelin basic protein thyroid hormone response element and its function in the context of native and heterologous promoter. The Journal of Biological Chemistry. 1992;267:15784–15788
  31. Lezoualc'h F, Hassan AH, Giraud P, et al. Assignment of the beta-thyroid hormone receptor to 3,5,3′-triiodothyronine-dependent inhibition of transcription from thyrotropin-releasing hormone promoter in chick hypothalamic neurons. Molecular Endocrinology. 1992;6:1797–1804
  32. Hollenberg AN, Monden T, Wondisford FE. Ligand-independent and -dependent functions of thyroid hormone receptor isoforms depend upon on their distinct amino terminal. Journal of Biological Chemistry. 1995;270:14272–14280
  33. Abel ED, Kaulbach HC, Campos-Barros A, et al. Novel insight from transgenic mice into thyroid hormone resistance and the regulation of thyrotropin. The Journal of Clinical Investigation. 1999;103:271–279
  34. Yen PM, Feng X, Flamant F, et al. Effects of ligand and thyroid hormone receptor isoforms on hepatic gene expression profiles of thyroid hormone receptor knock-out mice. EMBO Reports. 2003;4:581–587
  35. Williams GR, Brent GA. Thyroid hormone response elements. In:  Weintraub B editors. Molecular Endocrinology: Basic Concepts and Clinical Correlations. New York: Raven Press; 1995;p. 217–239
  36. Glass CK. Differential recognition of target genes by nuclear receptor monomers, dimers and heterodimers. Endocrine Reviews. 1994;15:391–407
  37. Yen PM, Brubaker JH, Apriletti JW, et al. Roles of T3 and DNA-binding on thyroid hormone receptor complex formation. Endocrinology. 1994;134:1075–1081
  38. Horlein AJ, Naar AM, Heinzel T, et al. Ligand-independent repression by the thyroid hormone receptor mediated by a nuclear co-repressor. Nature. 1995;377:397–404
  39. Chen JD, Evans RM. A transcriptional co-repressor that interacts with nuclear hormone receptors. Nature. 1995;377:454–457
  40. Seol W, Choi HS, Moore DD. Isolation of proteins that interact specifically with the retinoid X receptor: two novel orphan receptors. Molecular Endocrinology. 1995;9:72–85
  41. Hu I, Lazar MA. Transcriptional Repression by Nuclear Hormone Receptors. Trends in Endocrinology and Metabolism. 2000;11:6–10
  42. Zhang J, Hu X, Lazar MA. A novel role for helix 12 of retinoid X receptor in regulating repression. Molecular and Cellular Biology. 1999;19:6448–6457
  43. Wong J, Shi YB, Wolffe AP. A role for nucleosome asembly in both silencing and actiation of the xenopus TR beta A gene by the thyroid hormone receptor. Genes and Development. 1996;9:2696–2711
  44. Anderson GW, Larson RJ, Oas DR, et al. Chicken ovalbumin upstream promoter-transcription factor (COUP-TF) modulates expression of the Purkinje cell protein-2 gene. A potential role for COUP-TF in repressing premature thyroid hormone action in the developing brain. The Journal of Biological Chemistry. 1998;273:16391–16399
  45. Baniahmad A, Ha I, Reinberg D, et al. Interaction of human thyroid hormone receptor b with transcription factor TFIIB may mediate target gene derepression and activation by thyroid hormone. Proceedings of the National Academy of Sciences of the United States of America. 1993;90:8832–8836
  46. Hadzic E, Desai-Yajnik V, Helmer E, et al. A 10 amino acid sequence in the N-terminal A/B domain of thyroid hormone receptor alpha is essential for transcriptional activation and interaction with the general transcription factor TFIIB. Molecular and Cellular Biology. 1995;15:4507–4517
  47. Flamant F, Samarut J. Thyroid hormone receptor: lessons from knock-out and knock-in mice. Trends in Endocrinology and Metabolism. 2003;14:85–90
  48. Forrest D, Vennstrom B. Functions of thyroid hormone receptors in mice. Thyroid. 2000;10:41–52
  49. Onate SA, Tsai SY, Tsai MJ, et al. Sequence and characterization of a coactivator for the steroid hormone receptor superfamily. Science. 1995;270:1354–1357
  50. McInerney EM, Rose DW, Flynn SE, et al. Determinants of coactivator LXXLL motif specificity in nuclear receptor transcriptional activation. Genes & Development. 1998;12:3357–3368
  51. Heery DM, Kalkhoven E, Hoare S, et al. A signature motif in transcriptional co-activators mediates binding to nuclear receptors. Nature. 1997;387:733–736
  52. Torchia J, Glass C, Rosenfeld MG. Co-activators and co-repressors in the integration of transcriptional responses. Current Opinion in Cell Biology. 1998;10:373–383
  53. Nakajima T, Uchida C, Anderson SF, et al. RNA helicase A mediates association of CBP with RNA polymerase II. Cell. 1997;90:1107–1112
  54. Ito M, Roeder RG. The TRAP/SMCC/Mediator complex and thyroid hormone receptor function. Trends in Endocrinology and Metabolism. 2001;12:127–134
  55. Rachez C, Freedman LP. Mediator complexes and transcription. Current Opinion in Cell Biology. 2001;13:274–280
  56. Ko L, Cardona GR, Chin WW. Thyroid hormone receptor-binding protein, an LXXLL motif-containing protein, functions as a general coactivator. Proceedings of the National Academy of Sciences of the United States of America. 2000;97:6212–6217
  57. Ko L, Chin WW. Nuclear receptor coactivator thyroid hormone receptor-binding protein (TRBP) interacts with and stimulates its associated DNA-dependent protein kinase. The Journal of Biological Chemistry. 2003;278:11471–11479
  58. Jeyakumar M, Liu XF, Erdjument-Bromage H, et al. Phosphorylation of thyroid hormone receptor-associated NCoR corepressor holocomplex by the DNA-dependent protein kinase enhances its histone deacetylase activity. The Journal of Biological Chemistry. 2007;282:9312–9322
  59. DiRenzo J, Shang Y, Phelan M, et al. BRG-1 is recruited to estrogen-responsive promoters and cooperates with factors involved in histone acetylation. Molecular and Cellular Biology. 2000;20:7541–7549
  60. Sharma D, Fondell JD. Ordered recruitment of histone acetyltransferases and the TRAP/Mediator complex to thyroid hormone-responsive promoters in vivo. Proceedings of the National Academy of Sciences of the United States of America. 2002;99:7934–7939
  61. Shang Y, Hu X, DiRenzo J, et al. Cofactor dynamics and sufficiency in estrogen receptor-regulated transcription. Cell. 2000;103:843–852
  62. Reid G, Hubner MR, Metivier R, et al. Cyclic, proteasome-mediated turnover of unliganded and liganded ERalpha on responsive promoters is an integral feature of estrogen signaling. Molecular Cell. 2003;11:695–707
  63. Liu Y, Xia X, Fondell JD, et al. Thyroid hormone-regulated target genes have distinct patterns of coactivator recruitment and histone acetylation. Molecular Endocrinology. 2006;20:483–490
  64. Li X, Wong J, Tsai SY, et al. Progesterone and glucocorticoid receptors recruit distinct coactivator complexes and promote distinct patterns of local chromatin modification. Molecular and Cellular Biology. 2003;23:3763–3773
  65. Bodenner DL, Mroczynski MA, Weintraub BD, et al. A detailed functional and structural analysis of a major thyroid hormone inhibitory element in the human thyrotropin beta-subunit gene. The Journal of Biological Chemistry. 1991;266:21666–21673
  66. Hollenberg AN, Monden T, Flynn TR, et al. The human thyrotropin-releasing hormone gene is regulated by thyroid hormone through two distinct classes of negative thyroid hormone response elements. Molecular Endocrinology. 1995;9:540–550
  67. Pernasetti F, Caccavelli L, Van de Weerdt C, et al. Thyroid hormone inhibits the human prolactin gene promoter by interfering with activating protein-1 and estrogen stimulations. Molecular Endocrinology. 1997;11:986–996
  68. Bassett JH, Harvey CB, Williams GR. Mechanisms of thyroid hormone receptor-specific nuclear and extra nuclear actions. Molecular and Cellular Endocrinology. 2003;213:1–11
  69. Tagami T, Madison LD, Nagaya T, et al. Nuclear receptor corepressors activate rather than suppress basal transcription of genes that are negatively regulated by thyroid hormone. Molecular and Cellular Biology. 1997;17:2642–2648
  70. Weiss RE, Xu J, Ning G, et al. Mice deficient in the steroid receptor co-activator 1 (SRC-1) are resistant to thyroid hormone. The EMBO Journal. 1999;18:1900–1904
  71. Ortiga-Carvalho TM, Shibusawa N, Nikrodhanond A, et al. Negative regulation by thyroid hormone receptor requires an intact coactivator-binding surface. The Journal of Clinical Investigation. 2005;115:2517–2523
  72. Sasaki S, Lesoon-Wood LA, Dey A, et al. Ligand-induced recruitment of a histone deacetylase in the negative-feedback regulation of the thyrotropin beta gene. The EMBO Journal. 1999;18:5389–5398
  73. Abel ED, Boers ME, Pazos-Moura C, et al. Divergent roles for thyroid hormone receptor beta isoforms in the endocrine axis and auditory system. The Journal of Clinical Investigation. 1999;104:291–300
  74. Safer JD, Langlois MF, Cohen R, et al. Isoform variable action among thyroid hormone receptor mutants provides insight into pituitary resistance to thyroid hormone. Molecular Endocrinology. 1997;11:16–26
  75. Davis PJ, Davis FB. Nongenomic actions of thyroid hormone. Thyroid. 1996;6:497–504
  76. Bergh JJ, Lin HY, Lansing L, et al. Integrin alphaVbeta3 contains a cell surface receptor site for thyroid hormone that is linked to activation of mitogen-activated protein kinase and induction of angiogenesis. Endocrinology. 2005;146:2864–2871
  77. Baumann CT, Maruvada P, Hager GL, et al. Nuclear cytoplasmic shuttling by thyroid hormone receptors. multiple protein interactions are required for nuclear retention. The Journal of Biological Chemistry. 2001;276:11237–11245
  78. Storey NM, Gentile S, Ullah H, et al. Rapid signaling at the plasma membrane by a nuclear receptor for thyroid hormone. Proceedings of the National Academy of Sciences of the United States of America. 2006;103:5197–5201
  79. Cao X, Kambe F, Moeller LC, et al. Thyroid hormone induces rapid activation of Akt/protein kinase B-mammalian target of rapamycin-p70S6K cascade through phosphatidylinositol 3-kinase in human fibroblasts. Molecular Endocrinology. 2005;19:102–112
  80. Hiroi Y, Kim HH, Ying H, et al. Rapid nongenomic actions of thyroid hormone. Proceedings of the National Academy of Sciences of the United States of America. 2006;103:14104–14109[Epub 12006 Sep 14111]
  81. Klein I, Ojamaa K. Thyroid hormone and the cardiovascular system. The New England Journal of Medicine. 2001;344:501–509
  82. Moeller LC, Dumitrescu AM, Refetoff S. Cytosolic action of thyroid hormone leads to induction of hypoxia-inducible factor-1alpha and glycolytic genes. Molecular Endocrinology. 2005;19:2955–2963
  83. Wrutniak-Cabello C, Casas F, Cabello G. Thyroid hormone action in mitochondria. Journal of Molecular Endocrinology. 2001;26:67–77
  84. Casas F, Daury L, Grandemange S, et al. Endocrine regulation of mitochondrial activity: involvement of truncated RXRalpha and c-Erb Aalpha1 proteins. The FASEB Journal. 2003;17:426–436
  85. Davis PJ, Davis FB, Cody V. Membrane receptors mediating thyroid hormone action. Trends in Endocrinology and Metabolism. 2005;16:429–435
  86. Shih A, Lin HY, Davis FB, et al. Thyroid hormone promotes serine phosphorylation of p53 by mitogen-activated protein kinase. Biochemistry. 2001;40:2870–2878
  87. Cheng SY, Gong QH, Parkison C, et al. The nucleotide sequence of a human cellular thyroid hormone binding protein present in endoplasmic reticulum. Journal of Biological Chemistry. 1987;262:11221–11227
  88. Kato H, Fukuda T, Parkison C, et al. Cytoplasmic thyroid hormone-binding protein is a monomer of pyruvate kinase. Proceedings of the National Academy of Sciences of the United States of America. 1990;86:7681–7685
  89. Ashizawa K, McPhie P, Lin KH, et al. An in vitro novel mechanism of regulating the activity of pyruvate kinase M2 by thyroid hormone and fructose 1,6 bisphosphate. Biochemistry. 1991;30:7105–7111
  90. Farwell AP, Safran M, Dubord S, et al. Degradation and recycling of the substrate-binding subunit of type II iodothyronine 5′deiodonase in astrocytes. Journal of Biological Chemistry. 1996;271:16369–16374
  91. Siegrist-Kaiser CA, Juge-Aubry C, Tranter MP, et al. Thyroxine-dependent modulation of actin polymerization in cultured astrocytes: a novel extranuclear action of thyroid hormone. Journal of Biological Chemistry. 1990;265:5296–5302
  92. Farwell AP, DiBenedetto DJ, Leonard JL. Thyroxine targets different pathways of internalization of type II iodothyronine 5′-deiodinase in astrocytes. Journal of Biological Chemistry. 1993;268:5055
  93. Underwood AH, Emmett JC, Ellis D, et al. A thyromimetic that decreases plasma cholesterol levels without increasing cardiac activity. Nature. 1986;324:425–429
  94. Taylor AH, Stephan ZF, Steele RE, et al. Beneficial effects of a novel thyromimetic on lipoprotein metabolism. Molecular Pharmacology. 1997;52:542–547
  95. Chiellini G, Apriletti JW, Yoshihara HA, et al. A high-affinity subtype-selective agonist ligand for the thyroid hormone receptor. Chemistry & Biology. 1998;5:299–306
  96. Grover GJ, Mellstrom K, Ye L, et al. Selective thyroid hormone receptor-beta activation: a strategy for reduction of weight, cholesterol, and lipoprotein (a) with reduced cardiovascular liability. Proceedings of the National Academy of Sciences of the United States of America. 2003;100:10067–10072
  97. Johansson L, Rudling M, Scanlan TS, et al. Selective thyroid receptor modulation by GC-1 reduces serum lipids and stimulates steps of reverse cholesterol transport in euthyroid mice. Proceedings of the National Academy of Sciences of the United States of America. 2005;102:10297–10302
  98. Scanlan TS, Suchland KL, Hart ME, et al. 3-Iodothyronamine is an endogenous and rapid-acting derivative of thyroid hormone. Nature Medicine. 2004;10:638–642
  99. Morkin E, Ladenson P, Goldman S, et al. Thyroid hormone analogs for treatment of hypercholesterolemia and heart failure: past, present and future prospects. Journal of Molecular and Cellular Cardiology. 2004;37:1137–1146
  100. Mousa SA, O′Connor L, Davis FB, et al. Proangiogenesis action of the thyroid hormone analog 3,5-diiodothyropropionic acid (DITPA) is initiated at the cell surface and is integrin mediated. Endocrinology. 2006;147:1602–1607

PII: S1521-690X(07)00034-6

doi: 10.1016/j.beem.2007.04.004

Best Practice & Research Clinical Endocrinology & Metabolism
Volume 21, Issue 2 , Pages 193-208 , June 2007

Article Tools

* Image Usage & Resolution